Skip to main content Skip to main navigation menu Skip to site footer
logo Mediterranean Journal of Hematology and Infectious Diseases

eISSN 2035-3006

  • Home
  • About the Journal
  • Editorial Board
  • Current
  • Archives
  • Announcements
  • Register
  • Login
  • Journal Statistics
  • Search
  • Contact
  • Announcements

Editor-in-Chief: Giuseppe Leone | Italy

2.3
Impact Factor 2025
3.2
CiteScore 2025
2.3
Impact Factor 2025
3.2
CiteScore 2025
Submit
an article
  1. Home /
  2. Search

Search

Advanced filters
Published After
Published Before

Search Results

##search.searchResults.foundPlural##
  • NEW STRATEGIES FOR STEM CELL MOBILIZATION

    Roberto Lemoli
    e2012066
    2012-10-03
    https://doi.org/10.4084/mjhid.2012.066
    2512
    PDF: 900
    HTML: 2552
  • Atypical evolution of a Vaso-Occlusive presentation in Sickle Cell Disease: lessons in diagnostic vigilance

    Cristina Giubbilei, Elena Angeli, Fiammetta Fossi, Agnese Baffioni, Ginevra Giustini, Valentina Carrai
    2026-04-30
    https://doi.org/10.4084/MJHID.2026.042
    208
    HTML: 482
    PDF: 150
  • Azacytidine failure revisited: an appraisal based on real life data from the MDS registry of the Hellenic Myelodysplastic Syndrome Study Group (HMDS). Azacytidine failure revisited

    IOANNIS KOTSIANIDIS
    e2019045
    2019-06-25
    https://doi.org/10.4084/mjhid.2019.045
    1131
    PDF: 889
    HTML: 280
  • A case of iron deficiency anemia with co-existing Hb Fontainebleau.

    Abhishek HL Purohit, Mukul Aggarwal, Roshan B Colah, Anita H Nadkarni, Hara P Pati
    e2014051
    2014-06-29
    https://doi.org/10.4084/mjhid.2014.051
    1416
    PDF: 782
    HTML: 2078
    Untitled: 314
  • EPIDEMIOLOGY OF CARBAPENEM RESISTANT KLEBSIELLA PNEUMONIAE INFECTIONS IN MEDITERRANEAN COUNTRIES

    Corrado Girmenia, Martina Canichella, Alessandra Serrao
    e2016032
    2016-06-01
    https://doi.org/10.4084/mjhid.2016.032
    5024
    PDF: 1635
    HTML: 2493
  • Cardiac toxicity associated with HCV direct antiviral agents Heart in HCV DAAs therapy

    Claudio Ucciferri, Alessandro Occhionero, Jacopo Vecchiet, Katia Falasca
    e2018069
    2018-10-29
    https://doi.org/10.4084/mjhid.2018.069
    1640
    PDF: 1006
    HTML: 223
  • LIGHT CHAIN AMYLOIDOSIS

    Paolo Milani, Giampaolo Merlini, Giovanni Palladini
    e2018022
    2018-03-01
    https://doi.org/10.4084/mjhid.2018.022
    5951
    PDF: 2383
    HTML: 1515
  • HEPATITIS B AND C IN HEMATOPOIETIC STEM CELL TRANSPLANT

    Anna Locasciulli, Barbara Montante, Emanuela Morelli, Virginia Gulino, Anna Proia, Maria Beatrice Pinazzi
    e2009016
    https://doi.org/10.4084/mjhid.2009.016
    1017
    PDF: 546
    HTML: 734
  • Protein S deficiency with recurrent thromboembolism in a patient with hemoglobin H disease following splenectomy

    Kun Yang
    e2024017
    2024-02-29
    https://doi.org/10.4084/MJHID.2024.017
    643
    PDF: 1080
    HTML: 113
  • MILD BLEEDERS: DIAGNOSIS IS ELUSIVE IN LARGE NUMBER OF PATIENTS

    Mrinalini kotru, Deepti Mutereja, Abhishek Purohit, Seema Tyagi, Manoranjan Mahapatra, Renu Saxena, Hara Prasad Pati
    e2016049
    2016-10-17
    https://doi.org/10.4084/mjhid.2016.049
    3364
    PDF: 739
    HTML: 755
    Figure 1 Distribution of the various causes of mild bleeding (in %) in males and females: 198
    Figure 2 Age and Sex distribution of patients with Bleeding disorders- Unclassified: 200
    Table : Distribution of the sites of bleeding and their causes: 194
  • Interstitial pneumonia triggered by H1N1 influenza A virus as the initial presentation of chronic myeloid leukemia

    Zhan Su, Feng Wang
    e2025063
    2025-08-31
    https://doi.org/10.4084/MJHID.2025.063
    912
    PDF: 525
    HTML: 233
    Suppl. Files: 336
  • THERAPEUTIC VALUE OF COMBINED THERAPY WITH DEFERASIROX AND SILYMARIN ON IRON OVERLOAD IN CHILDREN WITH BETA THALASSEMIA

    adel abd elhaleim hagag
    e2013065
    2013-11-04
    https://doi.org/10.4084/mjhid.2013.065
    2779
    PDF: 856
    HTML: 15023
    Therapeutic Value of Combined Therapy with Deferasirox and Silymarin on Iron Overload in Children with Beta Thalassemia: 332
  • COMPARISON OF INFECTIOUS COMPLICATIONS IN PATIENTS RECEIVING HIGH-DOSE CYCLOPHOSPHAMIDE AS GVHD AFTER TRANSPLANTATION FROM A 9/10 HLA-MATCHED UNRELATED DONOR WITH STANDARD GVHD PROPHYLAXIS AFTER TRANSPLANT FROM A FULL MATCHING DONOR Infection With PTCy Versus Standard GvHD Prophylaxis

    Selim SAYIN
    e2024016
    2024-02-29
    https://doi.org/10.4084/MJHID.2024.016
    1479
    PDF: 1359
    HTML: 111
  • RECENT ADVANCES IN THE DEFINITION OF THE MOLECULAR ALTERATIONS OCCURRING IN MULTIPLE MYELOMA MOLECULAR ALTERATIONS OCCURRING IN MM

    Ugo Testa, Elvira Pelosi, Germana Castelli, Giuseppe Leone
    e2023062
    2024-06-29
    https://doi.org/10.4084/MJHID.2024.062
    1316
    PDF: 1095
    HTML: 240
  • Epidemiological surveillance of SARSCov2 in β-Thalassemia Patients in the last two years: reinfection rate, insights and future challenges

    Lorenza Torti, Francesco Sorrentino, Laura Maffei, Paolo De Fabritiis, Elisabetta Abruzzese
    e2023007
    2023-01-01
    https://doi.org/10.4084/MJHID.2023.007
    1215
    PDF: 1054
    HTML: 467
  • VIRAL HEPATITIS A TO E IN SOUTH MEDITERRANEAN COUNTRIES

    Sanaa M. Kamal, Sara Mahmoud, Tamer Hafez, Runia EL Fouly
    e2010001
    2010-02-09
    https://doi.org/10.4084/mjhid.2010.001
    1284
    PDF: 669
    HTML: 7751
  • Zanubrutinib as upfront treatment in de-novo B-cell prolymphocytic leukemia: the case of two elderlies.

    Silvia Giorgi, Giovanna Leonardi, Monica Maccaferri, Elena Sbadili, Carlo Caterina, Giovanni Fera, Ambra Paolini, Leonardo Potenza, Anna Candoni, Mario Luppi, Roberto Marasca
    e2025061
    2025-08-31
    https://doi.org/10.4084/MJHID.2025.061
    1310
    PDF: 592
    Html: 231
  • THE START-UP OF THE FIRST HEMATOPOIETIC STEM CELL TRANSPLANTATION CENTER IN THE IRAQI KURDISTAN: A CAPACITY-BUILDING COOPERATIVE PROJECT BY THE HIWA CANCER HOSPITAL, SULAYMANIYAH, AND THE ITALIAN AGENCY FOR DEVELOPMENT COOPERATION

    Ignazio Majolino
    e2017031
    2017-04-15
    https://doi.org/10.4084/mjhid.2017.031
    2441
    PDF: 1037
    HTML: 2127
  • Probable autoimmune lymphoproliferative syndrome with monogenic lupus due to KRAS mutation - A rare encounter

    Amiya Nayak, Pratyusha Gudapati, Swapnil Tripathi, Jasmita Dass, Mukul Aggarwal, Pradeep Kumar
    e2024033
    2024-02-29
    https://doi.org/10.4084/MJHID.2024.033
    897
    PDF: 1156
    HTML: 112
  • POOR HEMOPOIETIC STEM CELL MOBILIZERS IN MULTIPLE MYELOMA : A SINGLE INSTITUTION EXPERIENCE

    Guillermo Jose Ruiz-Delgado, Avril Lopez-Otero, Ana Hernandez-Arizpe, Aura Ramirez-Medina, Guillermo Jose Ruiz-Argüelles
    e2010016
    2010-06-19
    https://doi.org/10.4084/mjhid.2010.016
    1208
    PDF: 785
    HTML: 588
  • REAL WORLD MULTIPLE MYELOMA REGISTRY FROM JORDAN, A DEVELOPING COUNTRY.

    Abdalla Awidi, Farah Qasem, A'sem Abu-Qamar, Batool Aqel, Rand Aladayleh, Ilham Alteerah, Ahmad Magableh, , Hisham Bawa”neh, Feras Al-fararjeh
    e2022031
    2022-04-28
    https://doi.org/10.4084/MJHID.2022.031
    1349
    PDF: 768
    HTML: 413
  • TREATMENT OF LOW-BLAST COUNT AML USING HYPOMETHYLATING AGENTS

    Eleonora De Bellis, Luana Fianchi, Francesco Buccisano, Marianna Criscuolo, Luca Maurillo, Laura Cicconi, Mattia Brescini, Maria Ilaria Del Principe, Ambra Di Veroli, Adriano Venditti, Francesco Lo-Coco, Maria Teresa Voso
    e2017045
    2017-07-01
    https://doi.org/10.4084/mjhid.2017.045
    4436
    PDF: 1792
    HTML: 1113
  • CAR-T CELL THERAPY IN LARGE B CELL LYMPHOMA CAR-T; Large B Cell Lymphoma; Salvage Therapy,

    Ugo Testa, Giuseppe Leone, Elvira Pelosi, Dr. Germana Castelli, Prof. Hohaus
    e2023066
    2023-10-30
    https://doi.org/10.4084/MJHID.2023.066
    3808
    PDF: 1513
    HTML: 320
  • EPIDEMIOLOGICAL AND CLINICAL CHARACTERISTICS OF PEDIATRIC COVID-19 IN THE TERTIARY CARE SYSTEM IN THAILAND: COMPARATIVE DELTA AND PRE-DELTA ERA Pediatric COVID-19 in Thailand during pre-Delta and Delta era

    Araya Satdhabudha, Chanapai Chaiyakulsil, Paskorn Sritipsukho, Phakatip Sinlapamongkolkul, Utairat Chaumrattanakul, Auchara Tangsathapornpong, Pornumpa Bunjoungmanee, Patcharapa Thaweekula, Amolchaya Kwankuac, Onsuthi Pharadornuwata, Tananya Lokanuwatsatiena, Pichaya Tantiyavarong, Pakarat Pranudomrata, Chatchai Mingmalairak
    e2022044
    2022-04-28
    https://doi.org/10.4084/MJHID.2022.044
    1125
    PDF: 614
    HTML: 282
  • 5-Azacytidine in chronic myelomonocytic leukemia: case report and review of literature

    Mariangela Greco, Marianna Criscuolo, Luana Fianchi, Livio Pagano, Maria Teresa Voso
    e2011011
    2011-03-14
    https://doi.org/10.4084/mjhid.2011.011
    1662
    PDF: 782
    HTML: 1124
201 - 225 of 225 items << < 1 2 3 4 5 
Make a Submission

Links

  • Editorial Board
  • Alert me!
  • Advertising
  • Scopus
  • DOAJ
  • Article Processing Charge

Information

  • For Readers
  • For Authors
  • For Librarians

Indexing

  • OpenAlex
  • Analytics

PubMed

MJHID CiteScore by Scopus

Clarivate Analytics

this journal is covered
by Clarivate Analytics

 

The Mediterranean Journal of Hematology and Infectious Diseases has been selected for coverage in Clarivate Analytics products and services. Beginning with V. 7 (1) 2015.

AskBisht

Indexed in AskBisht.com

Facebook

FOLLOW US

MJHID in EuroPub Database

EuroPub

CLL UpDate

Keywords

Mediterranean Journal of Hematology and Infectious Diseases

is owned by the U.C.S.C. and it is published by PAGEPress®, Pavia, Italy. The MJHID is indexed and abstracted in Science Citation Index Expanded and Journal Citation Reports/InCites beginning with V. 7 (1) 2015.

eISSN: 2035-3006

Info

  • About
  • Editorial Board
  • News
  • Advertising

Info Submission

  • Submission

Our App Is Free For Anyone!

© PAGEPress 2008-2026    •    PAGEPress® is a registered trademark property of PAGEPress srl, Italy    •    VAT: IT02125780185
This journal is published by PAGEPress® srl (Pavia, Italy), which is the data controller for all personal data processed through this platform. For full details on how your data is collected, used and protected, please read our Privacy Policy.